179 related articles for article (PubMed ID: 38062617)
1. Role of Basal Forebrain Neurons in Adrenomyeloneuropathy in Mice and Humans.
Gong Y; Laheji F; Berenson A; Li Y; Moser A; Qian A; Frosch M; Sadjadi R; Hahn R; Maguire CA; Eichler F
Ann Neurol; 2024 Mar; 95(3):442-458. PubMed ID: 38062617
[TBL] [Abstract][Full Text] [Related]
2. Targeted Brain Delivery of Dendrimer-4-Phenylbutyrate Ameliorates Neurological Deficits in a Long-Term ABCD1-Deficient Mouse Model of X-Linked Adrenoleukodystrophy.
Nemeth CL; Gӧk Ö; Tomlinson SN; Sharma A; Moser AB; Kannan S; Kannan RM; Fatemi A
Neurotherapeutics; 2023 Jan; 20(1):272-283. PubMed ID: 36207570
[TBL] [Abstract][Full Text] [Related]
3. Investigating ABCD1 mutations in a Taiwanese cohort with hereditary spastic paraplegia phenotype.
Hsu SL; Chen YH; Chou CT; Chou YT; Tsai YS; Hsiao CT; Liao YC; Lee YC
Parkinsonism Relat Disord; 2021 Nov; 92():7-12. PubMed ID: 34649108
[TBL] [Abstract][Full Text] [Related]
4. Impaired very long-chain acyl-CoA β-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction.
Wiesinger C; Kunze M; Regelsberger G; Forss-Petter S; Berger J
J Biol Chem; 2013 Jun; 288(26):19269-79. PubMed ID: 23671276
[TBL] [Abstract][Full Text] [Related]
5. Metformin-induced mitochondrial function and ABCD2 up-regulation in X-linked adrenoleukodystrophy involves AMP-activated protein kinase.
Singh J; Olle B; Suhail H; Felicella MM; Giri S
J Neurochem; 2016 Jul; 138(1):86-100. PubMed ID: 26849413
[TBL] [Abstract][Full Text] [Related]
6. ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy.
Baarine M; Beeson C; Singh A; Singh I
J Neurochem; 2015 May; 133(3):380-96. PubMed ID: 25393703
[TBL] [Abstract][Full Text] [Related]
7. ABCD1 Transporter Deficiency Results in Altered Cholesterol Homeostasis.
Buda A; Forss-Petter S; Hua R; Jaspers Y; Lassnig M; Waidhofer-Söllner P; Kemp S; Kim P; Weinhofer I; Berger J
Biomolecules; 2023 Aug; 13(9):. PubMed ID: 37759733
[TBL] [Abstract][Full Text] [Related]
8. Adenoassociated virus serotype 9-mediated gene therapy for x-linked adrenoleukodystrophy.
Gong Y; Mu D; Prabhakar S; Moser A; Musolino P; Ren J; Breakefield XO; Maguire CA; Eichler FS
Mol Ther; 2015 May; 23(5):824-834. PubMed ID: 25592337
[TBL] [Abstract][Full Text] [Related]
9. Caffeic acid phenethyl ester induces adrenoleukodystrophy (Abcd2) gene in human X-ALD fibroblasts and inhibits the proinflammatory response in Abcd1/2 silenced mouse primary astrocytes.
Singh J; Khan M; Singh I
Biochim Biophys Acta; 2013 Apr; 1831(4):747-58. PubMed ID: 23318275
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome Metabolism Contributes to PIEZO2-Mediated Mechanical Allodynia.
Gong Y; Laheji F; Berenson A; Qian A; Park SO; Kok R; Selig M; Hahn R; Sadjadi R; Kemp S; Eichler F
Cells; 2022 Jun; 11(11):. PubMed ID: 35681537
[TBL] [Abstract][Full Text] [Related]
11. Abcd1 deficiency accelerates cuprizone-induced oligodendrocyte loss and axonopathy in a demyelinating mouse model of X-linked adrenoleukodystrophy.
Martinović K; Bauer J; Kunze M; Berger J; Forss-Petter S
Acta Neuropathol Commun; 2023 Jun; 11(1):98. PubMed ID: 37331971
[TBL] [Abstract][Full Text] [Related]
12. HDAC inhibitor SAHA normalizes the levels of VLCFAs in human skin fibroblasts from X-ALD patients and downregulates the expression of proinflammatory cytokines in Abcd1/2-silenced mouse astrocytes.
Singh J; Khan M; Singh I
J Lipid Res; 2011 Nov; 52(11):2056-69. PubMed ID: 21891797
[TBL] [Abstract][Full Text] [Related]
13. Dendrimer-N-acetyl-L-cysteine modulates monophagocytic response in adrenoleukodystrophy.
Turk BR; Nemeth CL; Marx JS; Tiffany C; Jones R; Theisen B; Kambhampati S; Ramireddy R; Singh S; Rosen M; Kaufman ML; Murray CF; Watkins PA; Kannan S; Kannan R; Fatemi A
Ann Neurol; 2018 Sep; 84(3):452-462. PubMed ID: 30069915
[TBL] [Abstract][Full Text] [Related]
14. A Large Family with p.Arg554His Mutation in
Campopiano R; Femiano C; Chiaravalloti MA; Ferese R; Centonze D; Buttari F; Zampatti S; Fanelli M; Amatori S; D'Alessio C; Giardina E; Fornai F; Biagioni F; Storto M; Gambardella S
Genes (Basel); 2021 May; 12(5):. PubMed ID: 34069712
[TBL] [Abstract][Full Text] [Related]
15. Novel
Cho YK; Lee SY; Kim SW
Endocrinol Metab (Seoul); 2020 Mar; 35(1):188-191. PubMed ID: 32207279
[TBL] [Abstract][Full Text] [Related]
16. Management of adrenoleukodystrophy: From pre-clinical studies to the development of new therapies.
Ma CY; Li C; Zhou X; Zhang Z; Jiang H; Liu H; Chen HJ; Tse HF; Liao C; Lian Q
Biomed Pharmacother; 2021 Nov; 143():112214. PubMed ID: 34560537
[TBL] [Abstract][Full Text] [Related]
17. Beneficial Effects of the Direct AMP-Kinase Activator PXL770 in In Vitro and In Vivo Models of X-Linked Adrenoleukodystrophy.
Monternier PA; Parasar P; Theurey P; Gluais Dagorn P; Kaur N; Nagaraja TN; Fouqueray P; Bolze S; Moller DE; Singh J; Hallakou-Bozec S
J Pharmacol Exp Ther; 2022 Aug; 382(2):208-222. PubMed ID: 35764327
[TBL] [Abstract][Full Text] [Related]
18. Abcd2 is a strong modifier of the metabolic impairments in peritoneal macrophages of ABCD1-deficient mice.
Muneer Z; Wiesinger C; Voigtländer T; Werner HB; Berger J; Forss-Petter S
PLoS One; 2014; 9(9):e108655. PubMed ID: 25255441
[TBL] [Abstract][Full Text] [Related]
19. Intrathecal Adeno-Associated Viral Vector-Mediated Gene Delivery for Adrenomyeloneuropathy.
Gong Y; Berenson A; Laheji F; Gao G; Wang D; Ng C; Volak A; Kok R; Kreouzis V; Dijkstra IM; Kemp S; Maguire CA; Eichler F
Hum Gene Ther; 2019 May; 30(5):544-555. PubMed ID: 30358470
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of deuterium-stabilized (R)-pioglitazone-PXL065-for X-linked adrenoleukodystrophy.
Monternier PA; Singh J; Parasar P; Theurey P; DeWitt S; Jacques V; Klett E; Kaur N; Nagaraja TN; Moller DE; Hallakou-Bozec S
J Inherit Metab Dis; 2022 Jul; 45(4):832-847. PubMed ID: 35510808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
